Atorvastatin Calcium
Product Images NDC 43353-115

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 43353-115). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 10mg (43353 0115 45)

Atorvastatin Calcium 10 mg tablets packaging label showing 45 tablets. The label includes storage instructions, manufacturer details (Apotex Inc., Toronto, Canada), and is marked RX Only. The NDC number 43353-0115-45 is visible with barcode representation.*

FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Chemical Structure- Atorvastatin Calcium (Image 01)

Chemical structure of atorvastatin calcium, showing its molecular arrangement including phenyl rings, fluorophenyl group, hydroxyl groups, and calcium ion with associated molecules.*

FDA Label Image

Figure 1 (Image 02)

A line graph comparing cumulative incidence (%) over time (years) between Atorvastatin and placebo groups. The graph shows lower cumulative incidence with Atorvastatin compared to placebo, with data points extending to 3.5 years. Hazard ratio and p-value are indicated on the graph.*

FDA Label Image

Figure 2 (Image 03)

A line graph showing cumulative hazard (%) over time (years) up to 5 years. Two lines represent Placebo (dashed) and Atorvastatin (solid). The graph indicates lower cumulative hazard for Atorvastatin compared to Placebo during the follow-up period. The hazard ratio (HR) and p-value are noted on the graph.*

FDA Label Image

Figure 3 (Image 04)

A line chart depicting the percentage of subjects experiencing the first major cardiovascular event over time in years, comparing Atorvastatin 10 mg (dashed line) and Atorvastatin 80 mg (solid line). The graph shows cumulative event rates up to 5 years with a hazard ratio of 0.78 (0.69-0.89) and a p-value of 0.0002.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.